Khaled Nasr's Net Worth

Estimate Recalculated May 22, 2025 08:46PM EST

Who is Khaled Nasr

Khaled Nasr does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CORGENTECH INC, AVEDRO INC, TESARO, Inc., EnteroMedics Inc, Doximity, Inc., Invuity, Inc., Trius Therapeutics Inc, PMV Pharmaceuticals, Inc., GLAUKOS Corp, Braze, Inc., Eiger BioPharmaceuticals, Inc., Carbylan Therapeutics, Inc., Marketo, Inc., OBALON THERAPEUTICS INC, Restoration Robotics Inc, and Transcept Pharmaceuticals Inc.

SEC CIK

Khaled Nasr's CIK is 0001276600

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AVEDRO INC

Investor

Updated Nov 25, 2019


Form 4	-100.00%	-2.75M	—	—	Nov 25, 2019	—	Disposition	—	Nov 21
Form 4	—	—	—	—	Feb 19, 2019	2.74M	Options	—	Feb 19
Form 3	—	—	—	—	Feb 13, 2019	101.61K	—	—	—

Showing 3 results

TESARO, Inc.

Investor

Updated Aug 07, 2013


Form 4	-19.53%	-600.00K	—	—	Aug 07, 2013	2.47M	Disposition	—	Aug 05
Form 4	-66.60%	-6.12M	$13.50	—	Jul 05, 2012	3.07M	Buy-Options	—	Jul 03
Form 3	—	—	—	—	Jun 27, 2012	—	—	—	—

Showing 3 results

EnteroMedics Inc

Investor

Updated Nov 21, 2007


Form 4	—	—	—	—	Nov 21, 2007	1.55M	Options	—	Nov 20
Form 4	—	187.50K	$8.00	$1.50M	Nov 19, 2007	1.55M	Purchase	—	Nov 15
Form 3	—	—	—	—	Nov 14, 2007	—	—	—	—

Showing 3 results

Doximity, Inc.

Investor

Updated Dec 06, 2021

View Quote Details


Form 4	-32.74%	-4.23M	—	—	Dec 06, 2021	8.69M	Options	—	Dec 02
Form 4	-24.67%	-4.23M	—	—	Nov 15, 2021	12.92M	Options	—	Nov 12
Form 4	-20.00%	-4.29M	$24.57	-$105.39M	Jun 28, 2021	17.16M	Sale	—	Jun 28
Form 3	—	—	—	—	Jun 23, 2021	—	—	—	—

Showing 4 results

Invuity, Inc.

Investor

Updated Jun 22, 2015


Form 4	4.78%	49.30K	—	—	Jun 22, 2015	1.08M	Options	—	Jun 18
Form 3	—	—	—	—	Jun 11, 2015	—	—	—	—

Showing 2 results

CORGENTECH INC

Investor

Updated Feb 18, 2004


Form 4	-3.25%	-70.31K	—	—	Feb 18, 2004	2.10M	Options	—	Feb 18
Form 3	—	—	—	—	Feb 11, 2004	—	—	—	—

Showing 2 results

Trius Therapeutics Inc

Investor

Updated Aug 10, 2010


Form 4	-73.83%	-10.01M	$4.77	—	Aug 10, 2010	3.55M	Buy-Options	—	Aug 06
Form 3	—	—	—	—	Aug 02, 2010	—	—	—	—

Showing 2 results

PMV Pharmaceuticals, Inc.

Investor

Updated Jul 14, 2021

View Quote Details


Form 4	-9.48%	-471.77K	—	—	Jul 14, 2021	4.50M	Disposition	—	Jul 13
Form 4	-9.11%	-498.55K	—	—	May 12, 2021	4.97M	Disposition	—	May 10
Form 4	-15.41%	-997.11K	—	—	Mar 25, 2021	5.47M	Disposition	—	Mar 24
Form 4/A	0.87%	55.55K	$18.00	—	Oct 02, 2020	6.47M	Purchase	—	Sep 25 - Sep 29
Form 4	0.85%	55.00K	$18.00	$990.00K	Sep 29, 2020	6.52M	Purchase	—	Sep 25 - Sep 29
Form 3	—	—	—	—	Sep 24, 2020	—	—	—	—

Showing 6 results

GLAUKOS Corp

Investor

Updated Jun 30, 2015

View Quote Details


Form 4	—	—	—	—	Jun 30, 2015	2.60M	Options	—	Jun 30
Form 3	—	—	—	—	Jun 24, 2015	—	—	—	—

Showing 2 results

Braze, Inc.

Investor

Updated Feb 09, 2022

View Quote Details


Form 4	—	—	—	—	Feb 09, 2022	3.39M	Options	—	Feb 08
Form 4	-24.98%	-1.13M	$61.42	-$69.40M	Nov 23, 2021	3.39M	Sale	—	Nov 19
Form 3	—	—	—	—	Nov 16, 2021	—	—	—	—

Showing 3 results

Eiger BioPharmaceuticals, Inc.

Investor

Updated Oct 22, 2018

View Quote Details


Form 4	-14.83%	-237.26K	$12.06	-$2.86M	Oct 22, 2018	1.36M	Sale	—	Oct 18
Form 3	—	—	—	—	Mar 31, 2016	1.60M	—	—	—

Showing 2 results

Carbylan Therapeutics, Inc.

Investor

Updated Apr 14, 2015

View Quote Details


Form 4	21.26%	810.00K	$5.00	—	Apr 14, 2015	4.62M	Purchase	—	Apr 14
Form 3	—	—	—	—	Apr 08, 2015	—	—	—	—

Showing 2 results

Marketo, Inc.

Investor

Updated Jun 02, 2014


Form 4	-71.64%	-124.48K	$24.31	-$3.01M	Jun 02, 2014	49.27K	Sale	—	May 29 - May 30
Form 4	-17.35%	-848.00K	—	—	May 30, 2014	4.04M	Disposition	—	May 28
Form 4	-39.07%	-10.00K	$24.01	-$240.09K	May 22, 2014	15.60K	Sale	—	May 20 - May 21
Form 4	-36.95%	-15.00K	$22.96	-$344.43K	May 20, 2014	25.60K	Sale	—	May 16
Form 4	-100.00%	-34.46K	$24.27	-$836.43K	May 15, 2014	—	Sale	—	May 13 - May 14
Form 4	-14.63%	-848.00K	—	—	May 14, 2014	4.95M	Disposition	—	May 12
Form 4	-61.95%	-24.42K	$41.96	-$1.02M	Mar 03, 2014	15.00K	Sale	—	Feb 27 - Feb 28
Form 4	-61.55%	-33.05K	$40.33	-$1.33M	Feb 28, 2014	20.65K	Sale	—	Feb 26
Form 4	-18.79%	-1.35M	—	—	Feb 27, 2014	5.85M	Disposition	—	Feb 25
Form 4	-100.00%	-4.35K	$40.70	-$177.04K	Feb 18, 2014	—	Sale	—	Feb 13
Form 4	-5.89%	-451.49K	—	—	Feb 14, 2014	7.21M	Disposition	—	Feb 12
Form 4	-21.37%	-2.08M	$33.99	-$70.82M	Sep 18, 2013	7.66M	Sale	—	Sep 18
Form 4	—	—	—	—	May 22, 2013	9.75M	Options	—	May 22
Form 3	—	—	—	—	May 16, 2013	—	—	—	—

Showing 14 results

OBALON THERAPEUTICS INC

Investor

Updated Aug 08, 2019

View Quote Details


Form 4	12.32%	43.75K	$4.00	$100.00K	Aug 08, 2019	398.97K	Purchase	—	Aug 06
Form 4	44.79%	1.10M	$1.82	$2.00M	Aug 27, 2018	3.55M	Purchase	—	Aug 23
Form 4	—	—	—	—	Oct 12, 2016	2.45M	Options	—	Oct 12
Form 3	—	—	—	—	Oct 05, 2016	—	—	—	—

Showing 4 results

Venus Concept Inc.

Investor

Updated Nov 12, 2019

View Quote Details


Form 4	—	—	—	—	Nov 12, 2019	658.66K	Options	—	Nov 07
Form 4	—	4.29M	$0.47	$2.00M	Aug 22, 2019	4.29M	Purchase	—	Aug 20
Form 4	59.60%	2.00M	$1.50	$3.00M	Aug 13, 2018	5.36M	Purchase	—	Aug 09
Form 4	—	—	$7.00	—	Oct 17, 2017	3.36M	Options	—	Oct 16
Form 4	—	—	—	—	Oct 13, 2017	—	Acq/Dis	—	Oct 11
Form 3	—	—	—	—	Oct 11, 2017	—	—	—	—

Showing 6 results

Transcept Pharmaceuticals Inc

Investor

Updated Sep 23, 2011


Form 4	12.30%	217.23K	$7.24	$1.57M	Sep 23, 2011	1.98M	Purchase	—	Sep 21
Form 3	—	—	—	—	Sep 22, 2011	1.77M	—	—	—

Showing 2 results